Trade Mark Journal No.2026/043 23 October 2026

UK00004458471 12 October 2026 (5,42)

MiNiRoLu

International priority date claimed: 2 September 2026 (United States of America) (50085790)

Class 5: Pharmaceutical preparations for gene therapy for the treatment of hematologic disorders.
Class 42: Gene therapy research.

San Rocco Therapeutics LLC

Representative: Keystone Law Limited